Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.6%

2 terminated/withdrawn out of 55 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

7%

4 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
26(74.3%)
Phase 4
3(8.6%)
Phase 1
3(8.6%)
Phase 2
2(5.7%)
Phase 3
1(2.9%)
35Total
N/A(26)
Phase 4(3)
Phase 1(3)
Phase 2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials
NCT07561957Not ApplicableRecruiting

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Role: lead

NCT06280885Not ApplicableCompleted

A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy

Role: collaborator

NCT06646861Not ApplicableCompleted

Head and Neck Cancer Rehabilitation: The CaRe Feasibility Study

Role: collaborator

NCT07455422Not ApplicableNot Yet Recruiting

A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

Role: collaborator

NCT07411105Active Not Recruiting

Cognition in Older Adults With Cancer Receiving Systemic Anti-Cancer Therapy

Role: collaborator

NCT06523374Not ApplicableRecruiting

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Role: collaborator

NCT07314528Phase 2Not Yet Recruiting

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Role: lead

NCT07309549Not Yet Recruiting

The Extended Study of Prevalence of Infection in Intensive Care IV

Role: collaborator

NCT07160868Not ApplicableRecruiting

Obstructive Sleep Apnoea and Difficult Asthma (OSADA)

Role: lead

NCT06590077Not ApplicableEnrolling By Invitation

Impact of Aromatherapy on Wellbeing and Relaxation in Gynae Oncology Patients Post Treatment

Role: collaborator

NCT06550063Recruiting

HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes

Role: lead

NCT04647292Phase 2Recruiting

European Blood Pressure Intensive Control After Stroke

Role: collaborator

NCT06410053Recruiting

The All Ireland Infectious Diseases Cohort Project

Role: collaborator

NCT04602468Phase 4Active Not Recruiting

Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)

Role: collaborator

NCT03377660Terminated

Resection of the Esophagus and Subsequent Weight Loss

Role: collaborator

NCT06178237Not ApplicableNot Yet Recruiting

RADA16 for Reducing Drain Output Trajectory Following Neck Dissection

Role: lead

NCT02385617Not ApplicableCompleted

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

Role: lead

NCT02381249Not ApplicableCompleted

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

Role: lead

NCT06097416Phase 3Not Yet Recruiting

Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer

Role: lead

NCT05968378Not ApplicableUnknown

Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease

Role: collaborator